IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs

Evgeny A Ermakov1, Evelina M Kabirova1, Valentina N Buneva1

  • 1Institute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 8 Lavrentiev Ave, 630090 Novosibirsk, Russia.

Insights

Multiple sclerosis (MS) patients

Area of Science:

  • Immunology
  • Neuroscience
  • Molecular Biology

Background:

  • Autoantibodies, previously identified as abzymes, can hydrolyze DNA, myelin basic protein, and oligosaccharides.
  • Specific microRNAs (miRNAs) show increased expression in the blood and cerebrospinal fluid of multiple sclerosis (MS) patients.
  • Autoantibodies capable of hydrolyzing miRNAs were initially discovered in schizophrenia patients.

Purpose of the Study:

  • To investigate the recognition and hydrolytic activity of IgG autoantibodies from MS patients against neuroregulatory and immunoregulatory miRNAs.
  • To characterize the specificity and efficiency of miRNA hydrolysis by MS patient-derived IgGs.

Main Methods:

  • Detection and characterization of IgG autoantibodies in the sera of MS patients.
  • Assay of IgG autoantibody recognition and hydrolysis of eight specific miRNAs (four neuroregulatory, four immunoregulatory).
  • Analysis of hydrolysis site specificity and relative activity (RA) of IgGs against miRNAs.
  • Statistical comparison of RA between MS patient groups and healthy donors.

Main Results:

  • MS patient IgG antibodies were found to effectively recognize and hydrolyze eight specific neuroregulatory and immunoregulatory miRNAs.
  • Hydrolysis was predominantly site-specific, with consistent major and moderate cleavage sites across most IgG preparations.
  • Significant differences in miRNA hydrolysis relative activity were observed between MS patients and healthy donors (p < 0.015).
  • A trend towards decreased miRNA hydrolysis efficiency was noted during disease remission compared to exacerbation.

Conclusions:

  • IgG autoantibodies in MS patients possess the intrinsic ability to recognize and hydrolyze specific neuroregulatory and immunoregulatory miRNAs.
  • The hydrolysis activity is largely site-specific, though variations exist among individuals and specific IgG preparations.
  • The findings suggest a potential role for these miRNA-hydrolyzing autoantibodies in the pathogenesis or as biomarkers of multiple sclerosis, with activity varying with disease state.

Related Concept Videos